Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Celldex Therapeutics, Inc. | a2223018zex-32.htm |
| EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc. | a2223018zex-31_2.htm |
| EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc. | a2223018zex-31_1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Celldex Therapeutics, Inc. | Financial_Report.xls |
| 10-K - 10-K - Celldex Therapeutics, Inc. | a2223018z10-k.htm |
| EX-4.1 - EX-4.1 - Celldex Therapeutics, Inc. | a2223018zex-4_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-182142, 333-189336, 333-151728, 333-117602 and 333-162423) and on Form S-3 (No. 333-192640) of Celldex Therapeutics, Inc. of our report dated February 24, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston,
Massachusetts
February 24, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM